SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-07-22 13:17
Tx date 2024-07-19 		$NGEN
NervGen Pharma Corp. 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$427,500
+150,000 vol
$2.85 each 		150,000
Filed 2024-07-22 13:16
Tx date 2024-07-19 		$NGEN
NervGen Pharma Corp. 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-17 10:35
Tx date 2023-03-17 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-43,961 vol 		4,885
Filed 2022-07-05 17:51
Tx date 2022-07-05 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$6,877
+1,525 vol
$4.51 each 		14,801
Filed 2022-06-10 14:44
Tx date 2022-06-07 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,020
+13,000 vol
$0.54 each 		48,846
Filed 2022-03-11 18:11
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-20,495.52
-2,979 vol
$6.88 each 		13,276
Filed 2022-03-11 18:07
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,708 vol 		16,255
Filed 2022-03-11 18:06
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,500 vol 		13,547
Filed 2022-03-11 18:05
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
57 - Exercise of rights
-2,708 vol 		7,917
Filed 2022-03-11 18:03
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
57 - Exercise of rights
-2,500 vol 		10,625
Filed 2022-03-11 17:56
Tx date 2022-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+200,000 vol 		768,809
Filed 2022-01-07 21:23
Tx date 2022-01-07 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$3,861
+277 vol
$13.94 each 		11,047
Filed 2021-07-13 14:26
Tx date 2021-07-05 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$39,300
+10,000 vol
$3.93 each 		35,846
Filed 2021-07-08 17:02
Tx date 2021-07-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$8,817
+299 vol
$29.49 each 		10,770
Filed 2021-03-12 18:12
Tx date 2021-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-49,808.7375
-1,425 vol
$34.95 each 		10,471
Filed 2021-03-12 18:09
Tx date 2021-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
+2,500 vol 		11,896
Filed 2021-03-12 18:07
Tx date 2021-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
57 - Exercise of rights
-2,500 vol 		13,125
Filed 2021-03-12 18:06
Tx date 2021-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+8,125 vol 		15,625
Filed 2021-03-12 18:05
Tx date 2021-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+48,750 vol 		568,809
Filed 2021-01-11 20:51
Tx date 2021-01-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$8,781
+284 vol
$30.92 each 		9,396
Filed 2020-12-13 23:05
Tx date 2020-12-09 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,331,132.50
-25,000 vol
$53.25 each 		9,112
Filed 2020-12-13 23:02
Tx date 2020-12-09 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$120,661
+16,620 vol
$7.26 each 		34,112
Filed 2020-12-13 22:58
Tx date 2020-12-09 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$45,000
+8,380 vol
$5.37 each 		17,492
Filed 2020-12-13 22:57
Tx date 2020-12-09 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-16,620 vol 		520,059
Filed 2020-12-13 22:55
Tx date 2020-12-09 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-8,380 vol 		536,679
Filed 2020-07-06 16:44
Tx date 2020-07-02 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$8,492
+277 vol
$30.66 each 		9,112
Filed 2020-06-11 12:08
Tx date 2020-06-08 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$140,600
+10,000 vol
$14.06 each 		25,846
Filed 2020-05-31 12:43
Tx date 2020-05-26 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
97 - Other 		$241,017
+15,846 vol
$15.21 each 		15,846
Filed 2020-05-31 12:42
Tx date 2020-05-26 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
97 - Other 		$-570,456
-15,846 vol
$36.00 each 		0
Filed 2020-03-11 20:11
Tx date 2020-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
56 - Grant of rights
+7,500 vol 		7,500
Filed 2020-03-11 20:10
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-11 20:09
Tx date 2020-03-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+45,000 vol 		545,059
Filed 2020-01-09 16:12
Tx date 2020-01-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$7,698
+394 vol
$19.54 each 		8,835
Filed 2019-12-13 09:59
Tx date 2019-12-13 		$LMNL
Liminal BioSciences Inc. (formerly Prometic Life Sciences Inc.) 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-15,830,354 vol 		15,846
Filed 2019-07-10 17:57
Tx date 2019-07-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,795
+464 vol
$12.49 each 		8,441
Filed 2019-06-07 15:55
Tx date 2019-06-04 		$PLI
Prometic Life Sciences Inc. 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$570,463
+15,846,200 vol
$0.036 each 		15,846,200
Filed 2019-06-07 15:53
Tx date 2019-05-08 		$PLI
Prometic Life Sciences Inc. 		Klompas, Neil
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-08 21:00
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-30,877.9624
-1,604 vol
$19.25 each 		7,977
Filed 2019-05-08 20:58
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$39,805
+8,380 vol
$4.75 each 		9,581
Filed 2019-05-08 20:57
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-128,854.9024
-6,704 vol
$19.22 each 		1,201
Filed 2019-05-08 20:53
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,000
+6,704 vol
$3.58 each 		7,905
Filed 2019-05-08 20:51
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-8,380 vol 		500,059
Filed 2019-05-08 20:49
Tx date 2019-05-06 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-6,704 vol 		508,439
Filed 2019-03-28
Tx date 2019-03-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$228,450
+15,000 vol
$15.23 each 		515,143
Filed 2019-01-10
Tx date 2019-01-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$5,166
+414 vol
$12.48 each 		1,201
Filed 2019-01-10
Tx date 2019-01-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options 		$1,397,700
+90,000 vol
$15.53 each 		500,143
Filed 2018-07-10
Tx date 2018-07-10 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,734
+138 vol
$12.57 each 		787
Filed 2018-03-23
Tx date 2018-03-19 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+75,000 vol 		410,143
Filed 2018-01-08
Tx date 2018-01-08 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan 		$1,635
+249 vol
$6.57 each 		649
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
-20,851 vol 		335,143
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-24,915
-3,300 vol
$7.55 each 		400
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-142.31
-19 vol
$7.49 each 		3,700
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,496
-200 vol
$7.48 each 		3,719
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-3,730
-500 vol
$7.46 each 		3,919
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-10,139.45
-1,361 vol
$7.45 each 		4,419
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-743.00
-100 vol
$7.43 each 		5,780
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,968
-400 vol
$7.42 each 		5,880
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,193.36
-296 vol
$7.41 each 		6,280
Filed 2017-12-30
Tx date 2017-12-28 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-25,160
-3,400 vol
$7.40 each 		6,576
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-1,532
-200 vol
$7.66 each 		9,976
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,885
-900 vol
$7.65 each 		10,176
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-5,866.75
-775 vol
$7.57 each 		11,076
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-756.00
-100 vol
$7.56 each 		11,851
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-66,440
-8,800 vol
$7.55 each 		11,951
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-741.00
-100 vol
$7.41 each 		20,751
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-2,220
-300 vol
$7.40 each 		20,851
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-735.00
-100 vol
$7.35 each 		21,151
Filed 2017-12-30
Tx date 2017-12-26 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$99,042
+20,851 vol
$4.75 each 		21,251
Filed 2017-06-15
Tx date 2017-06-12 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+85,000 vol 		355,994
Filed 2017-05-05
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
+400 vol 		400
Filed 2017-05-05
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-05
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Holder: Jennifer Heine (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$9,100
+700 vol
$13.00 each 		700
Filed 2017-05-05
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Holder: Jennifer Heine (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-05
Tx date 2017-04-27 		$ZYME
Zymeworks Inc. 		Klompas, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		270,994